Does metformin usage improve survival in head and neck squamous cell carcinoma? A population-based study

Does metformin usage improve survival in head and neck squamous cell carcinoma? A population-based study

Abstract Background We sought to expand upon preliminary data suggesting that metformin confers a survival benefit to patients with head and neck squamous cell carcinoma (HNSCC). Methods A large-scale retrospective cohort study of all patients in Ontario diagnosed with squamous cancer of the larynx,...

Full description

Bibliographic Details
Main Authors: Alexandra E. Quimby, Nicole L. Lebo, Rebecca Griffiths, Stephen Hall, Jim Dimitroulakos, Stephanie Johnson-Obaseki
Format: Article
Language:English
Published: BMC 2018-12-01
Series:Journal of Otolaryngology - Head and Neck Surgery
Subjects:
Squamous cell carcinoma
Metformin
Larynx
Hypopharynx
Nasopharynx
Online Access:http://link.springer.com/article/10.1186/s40463-018-0322-7

Internet

http://link.springer.com/article/10.1186/s40463-018-0322-7

Similar Items